Eversept Partners, LP Amarin Corp Plcuk Put Options Transaction History
Eversept Partners, LP
- $904 Million
- Q1 2025
Put Options
1 transactions
Others Institutions Holding AMRN
# of Institutions
162Shares Held
69.9MCall Options Held
172KPut Options Held
48.8K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$263 Million3.7% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12.4MShares$132 Million9.37% of portfolio
-
Morgan Stanley New York, NY2.62MShares$27.8 Million0.0% of portfolio
-
Waterfront Wealth Inc.2.51MShares$26.7 Million5.52% of portfolio
-
Scp Investment, LP2.5MShares$26.5 Million17.88% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $4.27B
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...